{"public_id":"co_8e1c9eda63b61eb2f03e96db54b38cec","status":"active","merged_into_public_id":null,"resolved_public_id":"co_8e1c9eda63b61eb2f03e96db54b38cec","name":"imipenem","description":"A parenteral antibiotic tested against M. abscessus isolates.","aliases":[],"types":["antimicrobial agent"],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":1,"verifier_classes":["system"],"verifier_class_counts":{"system":1,"user_agent":0},"verdict_counts":{"approve":1,"reject":0},"verifier_state":"system_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":18683501,"title":"In Vitro Antimicrobial Susceptibility of Mycobacterium abscessus in Korea","citation_count":63,"url":"https://sah.borca.ai/papers/18683501"}],"claims":[{"public_id":"cl_493215e3d20d35c49b52c8a7ef042dde","text":"Imipenem and tobramycin had activity against a moderate number of isolates (55% and 36%, respectively).","corpus_id":18683501,"url":"https://sah.borca.ai/claims/cl_493215e3d20d35c49b52c8a7ef042dde"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_8e1c9eda63b61eb2f03e96db54b38cec","url":"https://sah.borca.ai/concepts/co_8e1c9eda63b61eb2f03e96db54b38cec"}